Literature DB >> 19141561

Large scale replication and meta-analysis of variants on chromosome 4q25 associated with atrial fibrillation.

Stefan Kääb1, Dawood Darbar, Charlotte van Noord, Josée Dupuis, Arne Pfeufer, Christopher Newton-Cheh, Renate Schnabel, Seiko Makino, Moritz F Sinner, Prince J Kannankeril, Britt M Beckmann, Subbarao Choudry, Brian S Donahue, Jan Heeringa, Siegfried Perz, Kathryn L Lunetta, Martin G Larson, Daniel Levy, Calum A MacRae, Jeremy N Ruskin, Annette Wacker, Albert Schömig, H-Erich Wichmann, Gerhard Steinbeck, Thomas Meitinger, André G Uitterlinden, Jacqueline C M Witteman, Dan M Roden, Emelia J Benjamin, Patrick T Ellinor.   

Abstract

AIMS: A recent genome-wide association study identified a haplotype block on chromosome 4q25 associated with atrial fibrillation (AF). We sought to replicate this association in four independent cohorts. METHODS AND
RESULTS: The Framingham Heart Study and Rotterdam Study are community-based longitudinal studies. The Vanderbilt AF Registry and German AF Network (AFNet) are case-control studies. Participants with AF (n = 3508) were more likely to be male and were older than referent participants (n = 12 173; Framingham 82 +/- 10 vs. 71 +/- 13 years; Rotterdam 73 +/- 8 vs. 69 +/- 9 years; Vanderbilt 54 +/- 14 vs. 57 +/- 14 years; AFNet 62 +/- 12 vs. 49 +/- 14 years). Single nucleotide polymorphism (SNP) rs2200733 was associated with AF in all four cohorts, with odds ratios (ORs) ranging from 1.37 in Rotterdam [95% confidence interval (CI) 1.18-1.59; P = 3.1 x 10(-5)] to 2.52 in AFNet (95% CI 2.22-2.8; P = 1.8 x 10(-49)). There also was a significant association between AF and rs10033464 in Framingham (OR 1.34; 95% CI 1.03-1.75; P = 0.031) and AFNet (OR 1.30; 95% CI 1.13-1.51; P = 0.0002), but not Vanderbilt (OR 1.16; 95% CI 0.86-1.56; P = 0.33). A meta-analysis of the current and prior AF studies revealed an OR of 1.90 (95% CI 1.60-2.26; P = 3.3 x 10(-13)) for rs2200733 and of 1.36 (95% CI 1.26-1.47; P = 6.7 x 10(-15)) for rs10033464.
CONCLUSION: The non-coding SNPs rs2200733 and rs10033464 are strongly associated with AF in four cohorts of European descent. These results confirm the significant relations between AF and intergenic variants on chromosome 4.

Entities:  

Mesh:

Year:  2009        PMID: 19141561      PMCID: PMC2663727          DOI: 10.1093/eurheartj/ehn578

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  44 in total

1.  Stable microreentrant sources as a mechanism of atrial fibrillation in the isolated sheep heart.

Authors:  R Mandapati; A Skanes; J Chen; O Berenfeld; J Jalife
Journal:  Circulation       Date:  2000-01-18       Impact factor: 29.690

Review 2.  New ideas about atrial fibrillation 50 years on.

Authors:  Stanley Nattel
Journal:  Nature       Date:  2002-01-10       Impact factor: 49.962

3.  Atrial fibrillation and dementia in a population-based study. The Rotterdam Study.

Authors:  A Ott; M M Breteler; M C de Bruyne; F van Harskamp; D E Grobbee; A Hofman
Journal:  Stroke       Date:  1997-02       Impact factor: 7.914

4.  A population-based study of the long-term risks associated with atrial fibrillation: 20-year follow-up of the Renfrew/Paisley study.

Authors:  Simon Stewart; Carole L Hart; David J Hole; John J V McMurray
Journal:  Am J Med       Date:  2002-10-01       Impact factor: 4.965

5.  Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study.

Authors:  A S Go; E M Hylek; K A Phillips; Y Chang; L E Henault; J V Selby; D E Singer
Journal:  JAMA       Date:  2001-05-09       Impact factor: 56.272

6.  Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality: the Framingham Heart Study.

Authors:  Thomas J Wang; Martin G Larson; Daniel Levy; Ramachandran S Vasan; Eric P Leip; Philip A Wolf; Ralph B D'Agostino; Joanne M Murabito; William B Kannel; Emelia J Benjamin
Journal:  Circulation       Date:  2003-05-27       Impact factor: 29.690

7.  Locus for atrial fibrillation maps to chromosome 6q14-16.

Authors:  Patrick T Ellinor; Jordan T Shin; Rachel K Moore; Danita M Yoerger; Calum A MacRae
Journal:  Circulation       Date:  2003-06-02       Impact factor: 29.690

8.  The non-synonymous coding IKr-channel variant KCNH2-K897T is associated with atrial fibrillation: results from a systematic candidate gene-based analysis of KCNH2 (HERG).

Authors:  Moritz F Sinner; Arne Pfeufer; Mahmut Akyol; Britt-Maria Beckmann; Martin Hinterseer; Annette Wacker; Siegfried Perz; Wiebke Sauter; Thomas Illig; Michael Näbauer; Claus Schmitt; H-Erich Wichmann; Albert Schömig; Gerhard Steinbeck; Thomas Meitinger; Stefan Kääb
Journal:  Eur Heart J       Date:  2008-01-25       Impact factor: 29.983

9.  KCNQ1 gain-of-function mutation in familial atrial fibrillation.

Authors:  Yi-Han Chen; Shi-Jie Xu; Said Bendahhou; Xiao-Liang Wang; Ying Wang; Wen-Yuan Xu; Hong-Wei Jin; Hao Sun; Xiao-Yan Su; Qi-Nan Zhuang; Yi-Qing Yang; Yue-Bin Li; Yi Liu; Hong-Ju Xu; Xiao-Fei Li; Ning Ma; Chun-Ping Mou; Zhu Chen; Jacques Barhanin; Wei Huang
Journal:  Science       Date:  2003-01-10       Impact factor: 47.728

10.  Mouse Pitx2 deficiency leads to anomalies of the ventral body wall, heart, extra- and periocular mesoderm and right pulmonary isomerism.

Authors:  K Kitamura; H Miura; S Miyagawa-Tomita; M Yanazawa; Y Katoh-Fukui; R Suzuki; H Ohuchi; A Suehiro; Y Motegi; Y Nakahara; S Kondo; M Yokoyama
Journal:  Development       Date:  1999-12       Impact factor: 6.868

View more
  82 in total

1.  Pitx2 prevents susceptibility to atrial arrhythmias by inhibiting left-sided pacemaker specification.

Authors:  Jun Wang; Elzbieta Klysik; Subeena Sood; Randy L Johnson; Xander H T Wehrens; James F Martin
Journal:  Proc Natl Acad Sci U S A       Date:  2010-05-10       Impact factor: 11.205

2.  Symptomatic response to antiarrhythmic drug therapy is modulated by a common single nucleotide polymorphism in atrial fibrillation.

Authors:  Babar Parvez; Joseph Vaglio; Shane Rowan; Raafia Muhammad; Gayle Kucera; Tanya Stubblefield; Shannon Carter; Dan Roden; Dawood Darbar
Journal:  J Am Coll Cardiol       Date:  2012-06-20       Impact factor: 24.094

3.  Can polymorphisms predict response to antiarrhythmic drugs in atrial fibrillation?

Authors:  James P Daubert; Geoffrey S Pitt
Journal:  J Am Coll Cardiol       Date:  2012-06-20       Impact factor: 24.094

4.  PITX2: a master regulator of cardiac channelopathy in atrial fibrillation?

Authors:  Na Li; Dobromir Dobrev; Xander H T Wehrens
Journal:  Cardiovasc Res       Date:  2016-01-17       Impact factor: 10.787

5.  Genetic mutations as risk predictors of atrial fibrillation recurrence after catheter ablation?

Authors:  Jennifer L Hall; Ana Barac; Emelia J Benjamin
Journal:  J Am Coll Cardiol       Date:  2010-02-23       Impact factor: 24.094

Review 6.  Arrhythmia pharmacogenomics: methodological considerations.

Authors:  Dan M Roden; Prince J Kannankeri; Dawood Darbar
Journal:  Curr Pharm Des       Date:  2009       Impact factor: 3.116

Review 7.  Emerging directions in the genetics of atrial fibrillation.

Authors:  Nathan R Tucker; Patrick T Ellinor
Journal:  Circ Res       Date:  2014-04-25       Impact factor: 17.367

8.  Common genetic polymorphism at 4q25 locus predicts atrial fibrillation recurrence after successful cardioversion.

Authors:  Babar Parvez; M Benjamin Shoemaker; Raafia Muhammad; Rachael Richardson; Lan Jiang; Marcia A Blair; Dan M Roden; Dawood Darbar
Journal:  Heart Rhythm       Date:  2013-02-19       Impact factor: 6.343

Review 9.  New advances in the genetic basis of atrial fibrillation.

Authors:  Saagar Mahida; Patrick T Ellinor
Journal:  J Cardiovasc Electrophysiol       Date:  2012-10-15

10.  Molecular genetics of atrial fibrillation.

Authors:  Samir B Damani; Eric J Topol
Journal:  Genome Med       Date:  2009-05-22       Impact factor: 11.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.